These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 22799022)
21. Liver X receptor modulators: a review of recently patented compounds (2009 - 2012). Loren J; Huang Z; Laffitte BA; Molteni V Expert Opin Ther Pat; 2013 Oct; 23(10):1317-35. PubMed ID: 23826715 [TBL] [Abstract][Full Text] [Related]
22. Liver X receptors at the intersection of lipid metabolism and atherogenesis. Lee SD; Tontonoz P Atherosclerosis; 2015 Sep; 242(1):29-36. PubMed ID: 26164157 [No Abstract] [Full Text] [Related]
24. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis. Fiévet C; Staels B Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522 [TBL] [Abstract][Full Text] [Related]
25. AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells. Yang J; Craddock L; Hong S; Liu ZM J Cell Biochem; 2009 Feb; 106(3):414-26. PubMed ID: 19125418 [TBL] [Abstract][Full Text] [Related]
26. Identification of a selective agonist for liver X receptor α (LXRα) via screening of a synthetic compound library. Li N; Xu Y; Feng T; Liu C; Li Y; Wang X; Si S J Biomol Screen; 2014 Apr; 19(4):566-74. PubMed ID: 24334278 [TBL] [Abstract][Full Text] [Related]
27. Quinoline-3-carboxamide containing sulfones as liver X receptor (LXR) agonists with binding selectivity for LXRbeta and low blood-brain penetration. Hu B; Bernotas R; Unwalla R; Collini M; Quinet E; Feingold I; Goos-Nilsson A; Wilhelmsson A; Nambi P; Evans M; Wrobel J Bioorg Med Chem Lett; 2010 Jan; 20(2):689-93. PubMed ID: 19962892 [TBL] [Abstract][Full Text] [Related]
28. Selective liver X receptor modulators (SLiMs): what use in human health? Viennois E; Mouzat K; Dufour J; Morel L; Lobaccaro JM; Baron S Mol Cell Endocrinol; 2012 Apr; 351(2):129-41. PubMed ID: 21907760 [TBL] [Abstract][Full Text] [Related]
29. Iristectorigenin B isolated from Belamcanda chinensis is a liver X receptor modulator that increases ABCA1 and ABCG1 expression in macrophage RAW 264.7 cells. Jun HJ; Hoang MH; Lee JW; Yaoyao J; Lee JH; Lee DH; Lee HJ; Seo WD; Hwang BY; Lee SJ Biotechnol Lett; 2012 Dec; 34(12):2213-21. PubMed ID: 23011313 [TBL] [Abstract][Full Text] [Related]
30. Liver X receptor: a cardinal target for atherosclerosis and beyond. Parikh M; Patel K; Soni S; Gandhi T J Atheroscler Thromb; 2014; 21(6):519-31. PubMed ID: 24695022 [TBL] [Abstract][Full Text] [Related]
31. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice. Teupser D; Kretzschmar D; Tennert C; Burkhardt R; Wilfert W; Fengler D; Naumann R; Sippel AE; Thiery J Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2009-15. PubMed ID: 18787185 [TBL] [Abstract][Full Text] [Related]
32. The discovery of tertiary-amine LXR agonists with potent cholesterol efflux activity in macrophages. Marino JP; Kallander LS; Ma C; Oh HJ; Lee D; Gaitanopoulos DE; Krawiec JA; Parks DJ; Webb CL; Ziegler K; Jaye M; Thompson SK Bioorg Med Chem Lett; 2009 Oct; 19(19):5617-21. PubMed ID: 19717304 [TBL] [Abstract][Full Text] [Related]
33. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells. Delvecchio CJ; Bilan P; Radford K; Stephen J; Trigatti BL; Cox G; Parameswaran K; Capone JP Mol Endocrinol; 2007 Jun; 21(6):1324-34. PubMed ID: 17405904 [TBL] [Abstract][Full Text] [Related]
34. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Jakobsson T; Treuter E; Gustafsson JÅ; Steffensen KR Trends Pharmacol Sci; 2012 Jul; 33(7):394-404. PubMed ID: 22541735 [TBL] [Abstract][Full Text] [Related]
35. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. Wong J; Quinn CM; Brown AJ Biochem J; 2006 Dec; 400(3):485-91. PubMed ID: 16901265 [TBL] [Abstract][Full Text] [Related]
36. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma. Na TY; Shin YK; Roh KJ; Kang SA; Hong I; Oh SJ; Seong JK; Park CK; Choi YL; Lee MO Hepatology; 2009 Apr; 49(4):1122-31. PubMed ID: 19105208 [TBL] [Abstract][Full Text] [Related]
37. Kaempferol ameliorates symptoms of metabolic syndrome by regulating activities of liver X receptor-β. Hoang MH; Jia Y; Mok B; Jun HJ; Hwang KY; Lee SJ J Nutr Biochem; 2015 Aug; 26(8):868-75. PubMed ID: 25959373 [TBL] [Abstract][Full Text] [Related]